NEUARTIGE PEPTIDE UND KOMBINATION AUS PEPTIDEN ZUR VERWENDUNG IN DER IMMUNTHERAPIE GEGEN OVARIALKARZINOM UND ANDERE KARZINOME
Provided is a peptide of up to 30 amino acids comprising the amino acid sequence of SEQ ID NO: 217 or one of SEQ ID NOs: 1 to 10, 12 to 216 and 218 to 640. Provided are inter alia also a nucleic acid encoding such peptide, a host cell comprising the same, a T-cell receptor reactive with such peptide...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | FRITSCHE, Jens MAHR, Andrea WEINSCHENK, Toni HÖRZER, Helen SINGH, Harpreet SCHOOR, Oliver |
| description | Provided is a peptide of up to 30 amino acids comprising the amino acid sequence of SEQ ID NO: 217 or one of SEQ ID NOs: 1 to 10, 12 to 216 and 218 to 640. Provided are inter alia also a nucleic acid encoding such peptide, a host cell comprising the same, a T-cell receptor reactive with such peptide and an activated T lymphocyte recognizing a cell which presents such peptide. Provided is also the use of any of the above in cancer treatment. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MA54884A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MA54884A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MA54884A3</originalsourceid><addsrcrecordid>eNqFjLEKwjAURbs4iPoJwvsBJyt0fZpn-qh5CTGp0KUUiZNooa7-u0Xs7HThnMOdZ2-hiD6wJnDkAiuCKAoqa_YsGNgKYDxPTqCJHmryFxIVRQMLKPLAxkQJJXl0TKBJj6Wt0TOeKvQNizXfW5SxJpgYLbPZrbsPafXbRbY-UjiUm9Q_2zT03TU90qs1uMuLIsftP_8BMyA6OA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NEUARTIGE PEPTIDE UND KOMBINATION AUS PEPTIDEN ZUR VERWENDUNG IN DER IMMUNTHERAPIE GEGEN OVARIALKARZINOM UND ANDERE KARZINOME</title><source>esp@cenet</source><creator>FRITSCHE, Jens ; MAHR, Andrea ; WEINSCHENK, Toni ; HÖRZER, Helen ; SINGH, Harpreet ; SCHOOR, Oliver</creator><creatorcontrib>FRITSCHE, Jens ; MAHR, Andrea ; WEINSCHENK, Toni ; HÖRZER, Helen ; SINGH, Harpreet ; SCHOOR, Oliver</creatorcontrib><description>Provided is a peptide of up to 30 amino acids comprising the amino acid sequence of SEQ ID NO: 217 or one of SEQ ID NOs: 1 to 10, 12 to 216 and 218 to 640. Provided are inter alia also a nucleic acid encoding such peptide, a host cell comprising the same, a T-cell receptor reactive with such peptide and an activated T lymphocyte recognizing a cell which presents such peptide. Provided is also the use of any of the above in cancer treatment.</description><language>fre</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220112&DB=EPODOC&CC=MA&NR=54884A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220112&DB=EPODOC&CC=MA&NR=54884A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FRITSCHE, Jens</creatorcontrib><creatorcontrib>MAHR, Andrea</creatorcontrib><creatorcontrib>WEINSCHENK, Toni</creatorcontrib><creatorcontrib>HÖRZER, Helen</creatorcontrib><creatorcontrib>SINGH, Harpreet</creatorcontrib><creatorcontrib>SCHOOR, Oliver</creatorcontrib><title>NEUARTIGE PEPTIDE UND KOMBINATION AUS PEPTIDEN ZUR VERWENDUNG IN DER IMMUNTHERAPIE GEGEN OVARIALKARZINOM UND ANDERE KARZINOME</title><description>Provided is a peptide of up to 30 amino acids comprising the amino acid sequence of SEQ ID NO: 217 or one of SEQ ID NOs: 1 to 10, 12 to 216 and 218 to 640. Provided are inter alia also a nucleic acid encoding such peptide, a host cell comprising the same, a T-cell receptor reactive with such peptide and an activated T lymphocyte recognizing a cell which presents such peptide. Provided is also the use of any of the above in cancer treatment.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFjLEKwjAURbs4iPoJwvsBJyt0fZpn-qh5CTGp0KUUiZNooa7-u0Xs7HThnMOdZ2-hiD6wJnDkAiuCKAoqa_YsGNgKYDxPTqCJHmryFxIVRQMLKPLAxkQJJXl0TKBJj6Wt0TOeKvQNizXfW5SxJpgYLbPZrbsPafXbRbY-UjiUm9Q_2zT03TU90qs1uMuLIsftP_8BMyA6OA</recordid><startdate>20220112</startdate><enddate>20220112</enddate><creator>FRITSCHE, Jens</creator><creator>MAHR, Andrea</creator><creator>WEINSCHENK, Toni</creator><creator>HÖRZER, Helen</creator><creator>SINGH, Harpreet</creator><creator>SCHOOR, Oliver</creator><scope>EVB</scope></search><sort><creationdate>20220112</creationdate><title>NEUARTIGE PEPTIDE UND KOMBINATION AUS PEPTIDEN ZUR VERWENDUNG IN DER IMMUNTHERAPIE GEGEN OVARIALKARZINOM UND ANDERE KARZINOME</title><author>FRITSCHE, Jens ; MAHR, Andrea ; WEINSCHENK, Toni ; HÖRZER, Helen ; SINGH, Harpreet ; SCHOOR, Oliver</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MA54884A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>fre</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>FRITSCHE, Jens</creatorcontrib><creatorcontrib>MAHR, Andrea</creatorcontrib><creatorcontrib>WEINSCHENK, Toni</creatorcontrib><creatorcontrib>HÖRZER, Helen</creatorcontrib><creatorcontrib>SINGH, Harpreet</creatorcontrib><creatorcontrib>SCHOOR, Oliver</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FRITSCHE, Jens</au><au>MAHR, Andrea</au><au>WEINSCHENK, Toni</au><au>HÖRZER, Helen</au><au>SINGH, Harpreet</au><au>SCHOOR, Oliver</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NEUARTIGE PEPTIDE UND KOMBINATION AUS PEPTIDEN ZUR VERWENDUNG IN DER IMMUNTHERAPIE GEGEN OVARIALKARZINOM UND ANDERE KARZINOME</title><date>2022-01-12</date><risdate>2022</risdate><abstract>Provided is a peptide of up to 30 amino acids comprising the amino acid sequence of SEQ ID NO: 217 or one of SEQ ID NOs: 1 to 10, 12 to 216 and 218 to 640. Provided are inter alia also a nucleic acid encoding such peptide, a host cell comprising the same, a T-cell receptor reactive with such peptide and an activated T lymphocyte recognizing a cell which presents such peptide. Provided is also the use of any of the above in cancer treatment.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | fre |
| recordid | cdi_epo_espacenet_MA54884A |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | NEUARTIGE PEPTIDE UND KOMBINATION AUS PEPTIDEN ZUR VERWENDUNG IN DER IMMUNTHERAPIE GEGEN OVARIALKARZINOM UND ANDERE KARZINOME |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T00%3A33%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FRITSCHE,%20Jens&rft.date=2022-01-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMA54884A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |